Penumbra - Stock Split History | PEN

Stock split history for Penumbra since 2022. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Penumbra Annual Stock Splits
Penumbra Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.613B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $211.539B 21.55
Edwards Lifesciences (EW) United States $54.047B 38.24
Alcon (ALC) Switzerland $30.420B 25.75
STERIS (STE) Ireland $17.586B 21.84
Teleflex (TFX) United States $9.674B 15.41
Fresenius Medical Care AG KGaA (FMS) Germany $8.703B 8.03
Globus Medical (GMED) United States $6.278B 32.03
Glaukos (GKOS) United States $2.668B 0.00
Integer Holdings (ITGR) United States $2.181B 17.06
Nevro (NVRO) United States $1.748B 0.00
Paragon 28 (FNA) United States $1.439B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.085B 16.61
Artivion (AORT) United States $0.547B 52.15